MENLO PARK, Calif., April 2, 2014 - Geron Corporation (GERN) today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at the 13th Annual Needham Healthcare Conference in New York. The presentation is scheduled to occur at 8:00 a.m. Eastern Time on Tuesday, April 8th.
A live webcast of the presentation will be available through the Investor Relations pages of Geron`s website or at http://wsw.com/webcast/needham65/GERN. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.
Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
Anna Krassowska, Ph.D.
Investor and Media Relations
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Geron Corp. via GlobeNewswire